Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis

Journal of Urology

Volumn 179, Issue 2, 2008, Pages 764-769

  Hauser, Paul J ^a   Dozmorov, Mikhail G ^a   Bane, Barbara L ^a   Slobodov, Gennady ^a   Culkin, Daniel J ^a   Hurst, Robert E ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA CITY UNIVERSITY   (United States)

Author keywords

Bladder; Cell differentiation; Cystitis, interstitial; Glycosaminoglycans; Urothelium

Indexed keywords

BIGLYCAN; CYTOKERATIN 18; CYTOKERATIN 20; DECORIN; EOSIN; GLYCOSAMINOGLYCAN; HEMATOXYLIN; PERLECAN; PROTEIN ZO1; SYNDECAN; SYNDECAN 1; UROPLAKIN; UVOMORULIN; BIOLOGICAL MARKER; KERATIN TYPE I; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PROTEOGLYCAN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ADULT; ARTICLE; BLADDER BIOPSY; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CYSTITIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION; UROTHELIUM; AGED; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CYSTITIS, INTERSTITIAL; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; KERATINS, TYPE I; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PROTEOGLYCANS; UROTHELIUM;

EID: 38849151206     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.09.022     Document Type: Article

References (20)

1. Graham E and Chai TC: Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 2006;7:440.
2. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE and Culkin DJ: Abnormal expression of molecular markers for bladder impermeability and differentiation in urothelium of interstitial cystitis patients. J Urol 2004;171:1554.
3. Leiby BE, Landis JR, Propert KJ and Andomaszewski JE: Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J Urol 2007;177:142.
4. Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai T and Zhang J: Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 2003;14:107.
5. Hu P, Meyers S, Liang FX, Deng FM, Kachar B, Zeidel ML et al: Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol Renal Physiol 2002;283:F1200.
6. Laguna P, Smedts F, Nordling J, Horn T, Bouchelouche K, Hopman A et al: Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. Am J Clin Pathol 2006;125:105.
7. Cross WR, Eardley I, Leese HJ and Southgate J: A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function. Am J Physiol Renal Physiol 2005.
8. Scriven SD, Booth C, Thomas D F M, Trejdosiewicz LK and Southgate J: Reconstitution of human urothelium from monolayer culture. J Urol 1997;158:1147.
9. Erickson DR, Tomaszewski JE, Kunselman AR, Bentley CM, Peters KM, Rovner ES et al: Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol 2005;173:93.
10. Murdoch AD, Liu B, Schwarting R, Tuan RS and Iozzo RV: Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 1994;42:239.
11. Dozmorov MG, Kyker KD, Saban R, Knowlton N, Dozmorov IM, Centola M et al: Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells. BMC Cancer 2006;6:12.
12. Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B and Iozzo RV: Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 1997;100:149.
13. Droguett R, Cabello-Verrugio C, Riquelme C and Brandan E: Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 2006;25:332.
14. Forsberg E and Kjellen L: Heparan sulfate: lessons from knockout mice. J Clin Invest 2001;108:175.
15. Zhang D, Kosman J, Carmean N, Grady R and Bassuk JA: FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tract. Am J Physiol Renal Physiol 2006;291:F481.
16. Bagai S, Rubio E, Cheng JF, Sweet R, Thomas R, Fuchs E et al: Fibroblast growth factor-10 is a mitogen for urothelial cells. J Biol Chem 2002;277:23828.
17. Tash JA, David SG, Vaughan ED Jr and Herzlinger DA: Fibroblast growth factor-7 regulates stratification of the bladder urothelium. J Urol 2001;166:2536.
18. Ghiselli G, Eichstetter I and Iozzo RV: A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem J 2001;359:153.
19. Li Q, Park PW, Wilson CL and Parks WC: Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002;111:635.
20. Apodaca G, Kiss S, Ruiz WG, Meyers S, Zeidel M and Birder L: Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol Renal Physiol 2003.